Skip Navigation

Staff Detail

Skip sharing on social media links


Kapogiannis, Bill G

Formal Title:

Medical Officer


Program Director, Adolescent Medicine Trials Network for HIV/AIDS Interventions





6710B ROCKLEDGE DRIVE Room 2150, MSC 7002
Bethesda ,MD 20817


Bill G. Kapogiannis, M.D., is a board-certified infectious disease specialist in pediatrics and internal medicine. He received his M.D. from the University of Illinois at Chicago, College of Medicine, and completed a four year Internal Medicine/Pediatrics Residency Program at the University of Illinois at Chicago before finishing a combined fellowship training in Infectious Diseases within the departments of Internal Medicine and Pediatrics at Emory University, Atlanta, Georgia. Part of Dr. Kapogiannis' research involved assembling, collecting, and analyzing immunologic data on an HIV-positive adolescent cohort in Atlanta. Dr. Kapogiannis is the Scientific Director of the Adolescent Trials Network for HIV/AIDS Interventions, which is evaluating interventions for treatment and management of HIV infection and its complications among youth, as well as the prevention of HIV transmission in the adolescent population, including HIV vaccine and microbicide studies.

Publications (PubMed):

Youth-specific considerations in the development of preexposure prophylaxis, microbicide, and vaccine research trials.
Introduction: Paving the way for biomedical HIV prevention interventions in youth.
Mortality trends in the US Perinatal AIDS Collaborative Transmission Study (1986-2004).
Rolling up our sleeves now to reap the benefits later: preparing the community for an adolescent HIV vaccine.
Pre-Exposure Prophylaxis (PrEP) for Adolescents and Young Adults at Risk for HIV Infection: Is an Ounce of Prevention Worth a Pound of Cure?
The acceptability and feasibility of an HIV preexposure prophylaxis (PrEP) trial with young men who have sex with men.
BOND National Institues of Health Home Home Division of Intramural Population Health Research